Ionis Pharmaceuticals (NasdaqGS:IONS) FY Conference January 13, 2026 11:15 AM ET Company ParticipantsBrett Monia - CEOConference Call ParticipantsJessica Fye - AnalystJessica Fye Great. Good morning, everyone. Welcome. My name's Jessica Fye, Large Cap Biotech Analyst at J.P. Morgan, and we're continuing the 44th Annual Healthcare Conference this morning with Ionis. You're going to hear a presentation from the management team, and then we're going to go into some Q&A. So if you have any questions in the room ...

Zimmer Biomet (NYSE:ZBH) FY Conference January 13, 2026 11:15 AM ET Company ParticipantsSuketu Upadhyay - CFOIvan Tornos - CEOConference Call ParticipantsRobbie Marcus - MedTech AnalystRobbie MarcusGood morning, everyone. I'm Robbie Marcus, the MedTech analyst at J.P. Morgan. Really happy to introduce our next speaker, CEO of Zimmer Biomet, Ivan Tornos. He'll do a presentation followed by some Q&A.Ivan TornosThank you.Good morning. The morning already started in an interesting way because I was getting my m ...

Edgewise Therapeutics (NasdaqGS:EWTX) FY Conference January 13, 2026 11:15 AM ET Company ParticipantsKevin Koch - CEOConference Call ParticipantsTessa Romero - Biotechnology Equity AnalystTessa RomeroWelcome, everyone, to the 44th Annual J.P. Morgan Healthcare Conference. My name is Tess Romero, and I'm one of the Senior Biotech Analysts here at J.P. Morgan. Our next presenting company is Edgewise Therapeutics, and presenting on behalf of the company, we have President and CEO Kevin Koch. Kevin, over to you ...

Alico (NasdaqGS:ALCO) FY 2026 Conference January 13, 2026 11:00 AM ET Company ParticipantsJohn Kiernan - CEOModeratorGood morning, everyone. It is my pleasure to introduce you to John Kiernan, CEO of Alico. Very fortunate to have worked with John for many years, and we're going to be talking about the transformation that he's leading Alico through this morning and get into some more details about what they've done to date and what they expect to do going forward. So, John, Alico, 125-year-old company. I gue ...

Alico (NasdaqGS:ALCO) FY 2026 Conference January 13, 2026 11:00 AM ET Company ParticipantsJohn Kiernan - CEOModeratorGood morning, everyone. It is my pleasure to introduce you to John Kiernan, CEO of Alico. Very fortunate to have worked with John for many years, and we're going to be talking about the transformation that he's leading Alico through this morning and get into some more details about what they've done to date and what they expect to do going forward. So, John, Alico, 125-year-old company. I gue ...

UiPath (NYSE:PATH) FY Conference January 13, 2026 11:00 AM ET Company ParticipantsAshim Gupta - CFO and COOConference Call ParticipantsScott Berg - Senior AnalystScott BergYes, we are goin g to get started. So wonderful. Hey, Alex, before you come up, can you grab the door for me? Thanks. I'd like a coffee with two sugars too. Totally kidding. Totally kidding. I don't drink coffee, so. Awesome. Thanks, everyone, for joining us today. My name is Scott Berg. I lead the enterprise software and SaaS research ef ...

MKS Instruments (NasdaqGS:MKSI) FY Conference January 13, 2026 11:00 AM ET Company ParticipantsMichelle M. McCarthy - Chief Accounting OfficerJohn T.C. Lee - CEOConference Call ParticipantsNone - Analyst 2None - Analyst 1James Ricchiuti - Senior AnalystJames RicchiutiGood morning. Welcome to the 28th Annual Needham Growth Conference. The next presentation will be a fireside with MKS. We're pleased to have with us this morning CEO John Lee, Michelle McCarthy, Chief Accounting Officer. Also in the audience is ...

The Bank of New York Mellon (NYSE:BK) Q4 2025 Earnings call January 13, 2026 11:00 AM ET Speaker1Good morning and welcome to the 2025 Fourth Quarter Earnings Conference Call hosted by BNY. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please note that this conference call and webcast will be recorded and will consist of copyrighted material. You may not record or rebroadcast these materials without BNY's consent. I will now turn the call over ...

Revolutionizing Immunology with Oral Medicines Nello Mainolfi, PhD, Founder, President & CEO Kymera Therapeutics J.P. Morgan Healthcare Conference | January 2026 Patient-first mentality, with urgency: Rapidly advancing first-in-industry oral degraders with biologics-like activity Forward Looking Statements Defining and surpassing clinical benchmarks: Demonstrated compelling clinical translation of degraders' impact on clinical endpoints This presentation contains forward-looking statements within the meanin ...

Agilent Technologies Padraig McDonnell, President & CEO J.P. Morgan Healthcare Conference January 13, 2026 2026 J.P. Morgan Healthcare Conference Safe harbor This presentation contains forward-looking statements (including, without limitation, statements on Agilent's (the "company" or "our") strategy, priorities, growth and growth opportunities, productivity, reinvestment, customer focus, evolving product mix, work environment and innovation plans; the effects of the Ignite Operating System; the size and gr ...